MedTech Alliance 2

MedTech Alliance 2

Singaporeedis.sg

Overview

MedTech Alliance 2 (MTA 2) is a Singapore-based accelerator and fund that invests in promising deep-tech startups at the seed and early stages. Its investment focus is on Advanced Manufacturing & Engineering and Health & Biomedical Sciences. It was established in 2018 as a consortium comprising Economic Development Innovations Singapore (EDIS), Accuron MedTech Group, and Lu Yoh-Chie, the founder of Biosensors International. MTA 2 was appointed as a co-investment partner by SPRING SEEDS Capital (the investment arm of the Singaporean government's enterprise agency) under the Startup SG Equity initiative.

Portfolio Companies

1

Website

edis.sg

Investments

CompanyDateStageLead
twoplus fertilityMay 2022SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSingapore
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.